Lynch syndrome (LS) is a well-established cancer predisposition syndrome with an increased risk of colorectal, endometrial, ovarian, and other malignancies resulting from germline mutations in DNA mismatch repair (MMR) genes MLH1, MSH2, MSH6, and PMS2 [5]. This evidence concerns the gene MRC1 and Leigh syndrome.